retatrutide phase 2 trial results obesity VisualAbstract: reduces body weight by 17.5% in patients with Lilly's triple agonist, retatrutide, successful

402,403,404 Adipose tissue hypoxia and inflammation may lead to adipocyte dysfunction and obesity-induced insulin resistance in HFD-fed models, as indicated by increased infiltration of adipose tissue macrophages (ATMs), activation of the NLRP3 inflammasome and increased levels of proinflammatory cytokines

The National Family Health Survey (NFHS-4, 2015-16) reported that 20.7% of women and 18.6% of men in the 15-49 age group were overweight or obese, underscoring the urgent need for effective weight-loss solutions

Meanwhile, Novo Nordisk sells a weight-loss specific version called Wegovy for obesity treatment

(4) Regenerating other antioxidants like vitamin C and vitamin E after they've been oxidised